Originated from 2016, BIOCHINA2024(EBC) is a convention with a scale of more than 20,000 participants. Associating with the scientific research, biotech and biopharma companies, government regulation agencies, and clinical institutions, the convention connected each sectors together for advancing the bio ecosystem in China. “Exhibition-Conference-Event”, are the three major components of BIOCHINA2024(EBC) - The exhibition covers raw materials, reagents, consumables, instruments and equipment, and technical services. The conference covers antibody drugs, cell and gene therapy, nucleic acid drugs, IVD, vaccine, and other innovative development categories. BIOCHINA2024(EBC) initiated with entrepreneurs, investors, scientists, and clinical experts to spreading their thoughts and inspirations of new technologies and projects.